1. Basic medical insurance: basic medical insurance is a security system specially set up by the government to solve the medical problems of urban and rural residents. At present, the basic medical insurance practiced in China mainly includes the basic medical insurance for urban workers, the basic medical insurance for urban and rural residents, and the new type of rural cooperative medical care in various forms.
2. Major illness insurance: Major illness insurance is an initiative to diversify and transfer the risk of major medical expenses faced by individuals or families. Governments and health insurance organizations at all levels will purchase catastrophic insurance for health insurance participants according to their contribution status, which is used to encourage healthy social insurance behavior.
3. Medical aid: Medical aid refers to the financial inputs for the treatment of poor people who are unable to work, do not have pension insurance or basic medical insurance, and cannot afford medical expenses.
4. Disease prevention and control: prevention is an important aspect of medical security. China implements a national health policy that focuses on prevention, supplemented by emergency relief, and carries out vaccination, special prevention and control, disease surveillance and research on vaccines for epidemic viruses.
5. Drug management: Drug management is an important aspect, based on the continuous improvement of the drug distribution system, strengthening the supervision of the quality of drugs, controlling unreasonable price increases, and guaranteeing the reasonable use of drugs by patients.
Overall, China's medical security measures are constantly improving and strengthening, for the general public to provide comprehensive, healthy, high-quality and efficient medical services has laid a solid legal and institutional foundation. In addition to the above medical security measures, China has also implemented a number of other medical security measures, as follows:
1. Management and evaluation of medical and health institutions: the management and evaluation of medical and health institutions is one of the State's daily supervision of various types of medical and health institutions, with the aim of standardizing the order of the health care market, and improving the level and quality of medical services. At the same time, the management and evaluation of medical and health institutions also provides legal, financial and fiscal protection for the development of medical institutions.
2, medical informatization: medical informatization refers to the use of information technology means of medical information management, storage, transmission and analysis work. This work can realize the medical service resources *** enjoy and interoperability, speed up the medical process, reduce medical costs, improve the quality of medical services and other aspects of the benefits.
3, Chinese herbal medicine protection: Chinese herbal medicine is an important part of traditional Chinese medicine, in order to further promote the protection of Chinese herbal medicine resources, production, quality, sales and other aspects of the work, China has carried out the protection of Chinese herbal medicine, planting and quality standards and a number of provisions and measures to protect the healthy development of the Chinese herbal medicine industry, and to provide patients with safer and more effective treatment of Chinese medicine.
4. Disease control programs: In response to different diseases and epidemics, China carries out corresponding disease control programs in different parts of the country, including vaccination, virus testing, epidemic prevention inspections, and guiding the public to do a good job of prevention.
In summary, China's medical security measures are constantly improving and advancing, aiming to safeguard the public's health and life safety, and promote the long-term development of the country's medical industry.
Legal basis:
Article 9 of the People's Republic of China*** and State Drug Administration Law
Local people's governments at or above the county level are responsible for the supervision and management of drugs within the administrative area, and unify the leadership, organization, and coordination of supervision and management of drugs and the response to drug safety emergencies within the administrative area, and to establish and improve the supervision and management of drugs and the work mechanism and the Information **** enjoyment mechanism. Article 10
People's governments at or above the county level shall incorporate drug safety work into the national economic and social development planning at this level, include the funding for drug safety work in the budget of the government at this level, and strengthen the construction of drug supervision and management capacity to provide security for drug safety work.
Article 11
The drug supervision and management department set up or designated by the drug professional and technical institutions, to undertake the implementation of drug supervision and management in accordance with the law required for the review, inspection, verification, monitoring and evaluation.
Article 12
The state establishes and improves the drug traceability system. The drug supervision and management department under the state council shall formulate unified standards and specifications for drug traceability, promote the sharing of drug traceability information, and realize the traceability of drugs. The state establishes a pharmacovigilance system to monitor, identify, evaluate and control adverse drug reactions and other harmful reactions related to the use of medicines.
Article 13
People's governments at all levels and their relevant departments, drug industry associations and others shall strengthen drug safety publicity and education, and carry out popularization of drug safety laws and regulations and other knowledge. News media shall carry out drug safety laws and regulations and other knowledge of public welfare propaganda, and drug violations of public opinion supervision. Publicity and reporting on drugs should be comprehensive, scientific, objective and impartial. Article XIV of the drug industry associations should strengthen industry self-discipline, establish and improve industry norms, promote the construction of industry integrity system, guide and supervise members to carry out drug production and management activities in accordance with the law. Article XV of the people's governments at or above the county level and its relevant departments in the drug development, production, operation, use and supervision and management of the work of units and individuals who have made outstanding contributions, in accordance with the relevant provisions of the State to give recognition and reward.